cAMP and the insulinotropic peptides that raise cAMP glucose-dependently increase the cytosolic free Ca2+ concentration ([Ca2+]i) in pancreatic β-cells, which is tightly linked to the potentiation of glucose-induced insulin release. We examined whether cAMP increases [Ca2+]i in specific cooperation only with glucose or also with other insulin secretagogues that act through different mechanisms. [Ca2+]i in single rat pancreatic β-cells was measured by dual-wavelength fura-2 microfluorometry. In the presence of a stimulatory concentration of glucose (8.3 mmol/l) and the moderate elevation in [Ca2+]i induced by it, forskolin, an activator of adenylyl cyclase, or dibutyryl cAMP produced a marked additional increase in [Ca2+]i but was ineffective at the basal 2.8 mmol/l glucose. These cAMP-elevating agents also potentiated the effect of tolbutamide on [Ca2+]i. The cAMP-induced increase in [Ca2+]i was completely and selectively inhibited by a blocker of cAMP-dependent protein kinase A (PKA), and by nitrendipine, a blocker of the L-type Ca2+ channel. However, in the presence of high KCl and the [Ca2+]i elevation induced by it, a rise in cAMP failed to further increase [Ca2+]i, whereas BAY K8644, an agonist of L-type Ca2+ channels, evoked an additional increase in [Ca2+]i. Under low Na+ conditions, the [Ca2+]i response to cAMP was observed in the majority of the cells. In the cells in which glucose at 4.5–5 mmol/l was inadequate to increase [Ca2+]i, the glucose together with a rise in cAMP often increased [Ca2+]i. Likewise, tolbutamide and a rise in cAMP acted in concert to increase [Ca2+]i. Thus, cAMP left-shifted the concentration-[Ca2+]i response relationship for glucose and tolbutamide. In conclusion, the cAMP-PKA pathway acts in selective synergism with glucose and tolbutamide to initiate [Ca2+]i signals in pancreatic β-cells. cAMP appears to regulate β-cell sensitivity to glucose and tolbutamide. In contrast, cAMP fails to cooperate with high KCl to increase [Ca2+]i. It is suggested that cAMP acts mainly on a site that is more proximal but functionally linked to the L-type Ca2+ channel, thereby finally increasing Ca2+ influx through this channel.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1996
cAMP-Signaling Pathway Acts in Selective Synergism With Glucose or Tolbutamide to Increase Cytosolic Ca2+ in Rat Pancreatic β-Cells
Kazuro Yaekura;
Kazuro Yaekura
Department of Physiology
Japan
First Department of Internal Medicine Kagoshima University School of Medicine, Kagoshima
Japan
Search for other works by this author on:
Masafumi Kakei;
Masafumi Kakei
First Department of Internal Medicine Kagoshima University School of Medicine, Kagoshima
Japan
Search for other works by this author on:
Toshihiko Yada
Toshihiko Yada
Department of Physiology
Japan
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Toshihiko Yada, Department of Physiology, Kagoshima University School of Medicine, 8–35–1 Sakuragaoka, Kagoshima 890, Japan.
Diabetes 1996;45(3):295–301
Article history
Received:
July 05 1995
Received:
October 26 1995
Accepted:
October 26 1995
PubMed:
8593933
Citation
Kazuro Yaekura, Masafumi Kakei, Toshihiko Yada; cAMP-Signaling Pathway Acts in Selective Synergism With Glucose or Tolbutamide to Increase Cytosolic Ca2+ in Rat Pancreatic β-Cells. Diabetes 1 March 1996; 45 (3): 295–301. https://doi.org/10.2337/diab.45.3.295
Download citation file:
61
Views